Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. - Wikidata - awgldk - TriplyDB

Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.

Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.

http://www.wikidata.org/entity/Q33672762

about

A1ATD patient 1 line 1 A1ATD patient 1 line 2 A1ATD patient 1 line 3 A1ATD patient 2 line 1 A1ATD patient 2 line 2 A1ATD patient 2 line 3 A1ATD patient 3 line 1 CN patient 1 line 1 CN patient 1 line 2 CN patient 1 line 3 FH patient 1 line 1 GSD1a patient 1 line 1 GSD1a patient 1 line 2 GSD1a patient 1 line 3 HT patient 1 line 1 HT patient 1 line 2 HT patient 1 line 3

P1343

Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells Human induced pluripotent stem cells for monogenic disease modelling and therapy Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs Two Effective Routes for Removing Lineage Restriction Roadblocks: From Somatic Cells to Hepatocytes Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells Using iPS Cells toward the Understanding of Parkinson's Disease Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems Modelling human disease with pluripotent stem cells iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery Induced pluripotent stem cells as a disease modeling and drug screening platform Human pluripotent stem cells for modelling human liver diseases and cell therapy Stem cell-derived liver cells for drug testing and disease modeling Pharmacogenomics of adverse drug reactions Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?Stem cell differentiation and human liver disease Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture Development and function of human cerebral cortex neural networks from pluripotent stem cells in vitro Translational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug Discovery Pluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineering Induced pluripotent stem cell potential in medicine, specifically focused on reproductive medicine Long-term culture of genome-stable bipotent stem cells from adult human liver Disease modeling using human induced pluripotent stem cells: lessons from the liver Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses Long-term culture of human liver tissue with advanced hepatic functions.Human stem cells for craniomaxillofacial reconstruction.Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems.From skin cells to hepatocytes: advances in application of iPS cell technology Mouse liver repopulation with hepatocytes generated from human fibroblasts.Turning straw into gold: directing cell fate for regenerative medicine.Concise review: Human pluripotent stem cell-based models for cardiac and hepatic toxicity assessment.Harnessing the potential of induced pluripotent stem cells for regenerative medicine.Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc.Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation.Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

P2860

Q93311378-FE99E78C-1AA9-400D-93FE-CF7A7E96EEE2 Q93311380-8406CFEA-E191-46E3-9154-975B8597CB94 Q93311382-DABB5282-F262-4836-B95E-FA07C5FE9DD3 Q93311384-D9C67510-264C-417A-97DD-4CA2E449B89B Q93311386-42E5DF72-4F0A-402A-9E38-DF1CB361CA5A Q93311388-D266D5B0-B806-49E4-81C6-6673DD61C486 Q93311390-AA6B3E9D-C8A1-437D-8978-338621C9F004 Q93455831-1AE2F00F-60D7-48EA-91F5-4D50E1FD970B Q93455835-20257FD3-BCA2-45D4-96A6-2BF2F5D49D1B Q93455838-9909427D-DBA7-4B04-AFC6-9ACC0C75DA0E Q93552507-7812B420-02D1-4474-B75D-14D6B6385B4D Q93935212-E75B2BFF-B71F-4D11-BDC8-ABCF9C850F38 Q93935214-A142B26C-E960-4D96-9DEA-7C7BED8D7CFC Q93935215-66E92D9C-09BE-4F66-8FA9-87F1FCED6940 Q94304149-689E063F-4C33-4F2C-956B-429F6452B33D Q94304154-9EE47BAE-FFCB-4F81-B716-C06223D9D4C1 Q94304159-9271485C-9184-4865-B47D-5716EBCF114E

P1343

Q24320041-91F1BE72-8F8B-4852-A899-4BCB618C2E85 Q24617599-09B6D7A3-D33B-4901-89F0-48024FA5C66F Q24634829-ACFC1821-F85A-4DD5-8228-E6033D5B5F9C Q26750393-569BF377-51BF-4811-BF75-168509759876 Q26767096-37BC5FB6-6F65-4E8E-8D6B-31376D4BCD5D Q26775061-69749EA7-B5CB-4CF0-8CCA-59CA31D73C90 Q26775122-C1C5F48B-2184-44F1-9BA3-591477F5A1FD Q26784188-C9914C4A-6769-4F81-82B8-38548C0CA783 Q26795447-F6656076-098E-405E-97B6-0378A23152F4 Q26798131-623F7310-2986-4378-8C89-98A8D7C9F236 Q26799590-0AED5E12-5E19-4AA3-A8CA-1346BFB30788 Q26799933-0F6A4F46-D66E-4E5C-8551-C1969960DC91 Q26864380-0EE85248-4B93-485A-8475-0AC098477F8A Q26865055-4E33F8C0-314D-49A6-A867-E34D41BA14B5 Q26865689-6A872575-4BA5-4979-8276-3C3C61C82694 Q27005360-02B2DE4F-2E18-46D9-AF2A-03B6CA428699 Q27012605-C8B66858-159D-412D-B23D-EBE0D9ECC19E Q27015820-5367551B-A832-4AD3-ADCA-0723011B95A0 Q27024267-37C16B4B-4829-482E-A5E7-B4BDFC7B556C Q27027529-45CCCC48-913E-440E-866F-5498B4885E67 Q27331365-25A2455F-4C3F-4892-B051-F371D15740F3 Q27342828-5109DD96-3C9D-42FB-A880-F79104A33EDB Q28072402-F6A9081F-97A4-4317-9339-85ED5DC849A9 Q28076413-049EE55B-3C9D-4103-AD22-379F26765478 Q28083057-EC09218F-D423-4A40-992C-32E905EDD2D9 Q28254408-1B729F6E-FE12-4956-928A-D78900779024 Q28650516-EB7D7B26-9A26-4866-BD09-B10F5BEE3D64 Q28818235-9BFED93B-CD3E-413E-96F1-9C5017769003 Q30562410-1E9918E2-E7D0-47D7-AD48-51E789DA4693 Q33752322-D75E3EE1-7525-4D60-B09D-5F4F605B4AB4 Q33788845-6356B412-ABDE-43BA-B8FF-9F75E92FC90C Q34082747-A7969501-694C-45CA-92D3-21B30ACDD7A4 Q34090265-C983E143-D33C-48A7-9CA3-52D3D87D7199 Q34165305-79E160AB-0F70-470E-BCA6-2799BBD8EE95 Q34169386-733A0502-D397-4634-8065-703114AEA957 Q34172962-419C2004-5F14-468A-ADB7-38F103EE1747 Q34182222-BA860350-3C0E-4FCE-879A-91956D3480DA Q34226581-08518939-B09A-48FB-A129-6FFC8D2C6A23 Q34229606-19B3B25E-FE2E-4DBC-BBF9-7FACE632ABB9 Q34231818-97516E98-236C-4CCE-B54A-6701C6ED433D

P2860

Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.

http://www.wikidata.org/entity/Q33672762

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Modeling inherited metabolic d ...... nduced pluripotent stem cells.

@ast

Modeling inherited metabolic d ...... nduced pluripotent stem cells.

@en

type

label

Modeling inherited metabolic d ...... nduced pluripotent stem cells.

@ast

Modeling inherited metabolic d ...... nduced pluripotent stem cells.

@en

prefLabel

Modeling inherited metabolic d ...... nduced pluripotent stem cells.

@ast

Modeling inherited metabolic d ...... nduced pluripotent stem cells.

@en

P1433

Q33672762-61F93EFB-C0D5-465A-9F40-DBF04B48C291

P1476

Q33672762-AF5B426A-5B19-4FBC-8C76-E715E92D2EF5

P2093

Q33672762-0E8E60BC-6BFD-4472-A3EE-53BE64EFAE84

Q33672762-5C286100-53E7-4A49-A72B-DCF6BF0642E7

Q33672762-5F93A48D-CB23-43E4-8C7B-EF74192B30B9

Q33672762-94730DC4-61FF-4850-853D-220ADAD6D0DA

Q33672762-9587F4EE-0ED3-43E6-8B58-FCE649A215E8

Q33672762-96678A8D-CFE1-47BB-9444-66D8DF4C6274

Q33672762-BBB9B0DD-9C26-4EF3-B250-A9EC2D0C4483

Q33672762-BE6471E8-8832-4ED9-95DC-5C30FB04E5B2

P2860

Q33672762-0AC1E7CF-1050-4190-AD50-053CB57FA54A

Q33672762-0B401100-18B3-4D5C-B1FD-F3E9B8B081C3

Q33672762-0F752057-9BF7-49BC-AD59-8C435EEECDFA

Q33672762-11497676-D00E-472F-A6D4-C35836435490

Q33672762-114FEF4B-D481-471F-AA5B-AE0E6BD6CDF7

Q33672762-1DACA7BD-44D3-480B-9F9B-EE6CF11D6176

Q33672762-44768796-B3C6-4558-B31A-89ADDDA51DAC

Q33672762-4510A715-D773-4429-A1BC-8D274B496FBA

Q33672762-506594B8-D1C6-489B-BA57-A69166AB15C7

Q33672762-506E3079-8A4D-455E-8E9B-C3DA7CE8C6A9

P304

Q33672762-52E6F993-1929-44BE-9728-B2F0E0C8E2FC

P31

Q33672762-B4242985-4574-459D-B269-79B256C79FF9

P356

Q33672762-43A8B4B2-BF50-4FBA-B43F-F62F14FDAF09

P407

Q33672762-826EDD27-D953-4957-AADD-281763A3E60D

P433

Q33672762-EE111CD6-8D91-4728-A4F8-CD79C67281DB

P478

Q33672762-24A7FC5C-1D6F-4FC8-8241-731D6F9F7828

P50

Q33672762-27C85F17-3338-4F97-B8B5-C946C75BCEB0

Q33672762-84066202-6C9C-4E29-AEF2-6D8AF9CDD6A6

Q33672762-8736D94E-2F36-403B-AD2E-29A3CE8ED028

Q33672762-A3033C6B-9FBC-40C8-8FAC-99BABA4DCC0E

Q33672762-C84872A7-68AE-4CE3-8810-077DD3B5575D

Q33672762-E3946F66-D1B9-4AEC-A3D6-3A1E30C9D8EF

P577

Q33672762-9C1EE714-B145-4E87-B062-CA421AE47E10

P5875

Q33672762-2959D581-FFFA-4D08-B997-C684AB98FC1F

P698

Q33672762-AC461F81-C857-4E80-9B88-83A6A386D73D

P921

Q33672762-C38460A1-F0AA-4C39-B567-2AD4661DA100

P932

Q33672762-D805BAF7-B47E-4C0A-BDE6-B1B7B15853C9

P356

P1433

Journal of Clinical Investigation

P1476

Modeling inherited metabolic d ...... induced pluripotent stem cells

@en

P2093

Anne Weber

http://www.w3.org/2001/XMLSchema#string

David A Lomas

http://www.w3.org/2001/XMLSchema#string

Graeme Alexander

http://www.w3.org/2001/XMLSchema#string

Isabel Huang-Doran

http://www.w3.org/2001/XMLSchema#string

Jeremy Skepper

http://www.w3.org/2001/XMLSchema#string

Julian Griffin

http://www.w3.org/2001/XMLSchema#string

Lars Ahrlund-Richter

http://www.w3.org/2001/XMLSchema#string

Sebastien Corbineau

http://www.w3.org/2001/XMLSchema#string

P2860

Disease-specific induced pluripotent stem cells

Monogenic hypercholesterolemia: new insights in pathogenesis and treatment

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Adapting proteostasis for disease intervention

Induced pluripotent stem cells from a spinal muscular atrophy patient

Derivation of pluripotent epiblast stem cells from mammalian embryos

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons

Organizational diversity among distinct glycoprotein endoplasmic reticulum-associated degradation programs

A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with alpha1-antitrypsin deficiency.

A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency.

P304

3127-3136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI43122

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

Robert K Semple

Stefan J Marciniak

Sheikh T. Rashid

Ludovic Vallier

Nicholas Hannan

P577

2010-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45952025

http://www.w3.org/2001/XMLSchema#string

P698

20739751

http://www.w3.org/2001/XMLSchema#string

P921

Human Induced Pluripotent Stem Cells

P932

2929734

http://www.w3.org/2001/XMLSchema#string